α-Synuclein aggregation

被引：8

作者：

Bodles, AM ^{[1
]}

Irvine, GB

机构：

[1] Univ Arkansas Med Sci, Donald W Reynolds Ctr Aging, Little Rock, AR 72205 USA

[2] Queens Univ Belfast, Sch Biol & Biochem, Ctr Med Biol, Peptide & Prot Res Grp, Belfast BT9 7BL, Antrim, North Ireland

来源：

PROTEIN AND PEPTIDE LETTERS | 2004年 / 11卷 / 03期

关键词：

alpha-synuclein; NAC; amyloid; aggregation; Parkinson's disease;

D O I：

10.2174/0929866043407084

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

alpha-Synuclein is a major component of Lewy bodies in Parkinson's disease and is found associated with several other forms of dementia. As with other neurodegenerative diseases, the ability of alpha-synuclein to aggregate and form fibrillar deposits seems central to its pathology. We have defined a sequence within the NAC region of alpha-synuclein that is necessary for aggregation. Exploitation of chemically modified analogues of this peptide may produce inhibitors of aggregation..

引用

页码：271 / 279

页数：9

共 46 条

[1] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].

Abeliovich, A ;

Schmitz, Y ;

Fariñas, I ;

Choi-Lundberg, D ;

Ho, WH ;

Castillo, PE ;

Shinsky, N ;

Verdugo, JMG ;

Armanini, M ;

Ryan, A ;

Hynes, M ;

Phillips, H ;

Sulzer, D ;

Rosenthal, A .

NEURON, 2000, 25 (01) :239-252

[2]

Baba M, 1998, AM J PATHOL, V152, P879

[3] α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores [J].

Bayer, TA ;

Jäkälä, P ;

Hartmann, T ;

Havas, L ;

McLean, C ;

Culvenor, JG ;

Li, QX ;

Masters, CL ;

Falkai, P ;

Beyreuther, K .

NEUROSCIENCE LETTERS, 1999, 266 (03) :213-216

[4] Inhibition of fibril formation and toxicity of a fragment of α-synuclein by an N-methylated peptide analogue [J].

Bodles, AM ;

El-Agnaf, OMA ;

Greer, B ;

Guthrie, DJS ;

Irvine, GB .

NEUROSCIENCE LETTERS, 2004, 359 (1-2) :89-93

[5] Toxicity of non-Aβ component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils [J].

Bodles, AM ;

Guthrie, DJS ;

Harriott, P ;

Campbell, P ;

Irvine, GB .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08) :2186-2194

[6] Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity [J].

Bodles, AM ;

Guthrie, DJS ;

Greer, B ;

Irvine, GB .

JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :384-395

[7]

Cabin DE, 2002, J NEUROSCI, V22, P8797

[8] A broken α-helix in folded α-synuclein [J].

Chandra, S ;

Chen, XC ;

Rizo, J ;

Jahn, R ;

Südhof, TC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) :15313-15318

[9] Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].

Conway, KA ;

Rochet, JC ;

Bieganski, RM ;

Lansbury, PT .

SCIENCE, 2001, 294 (5545) :1346-1349

[10] Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited -: NAC and α-synuclein are not associated with Aβ amyloid [J].

Culvenor, JG ;

McLean, CA ;

Cutt, S ;

Campbell, BCV ;

Maher, F ;

Jäkälä, P ;

Hartmann, T ;

Beyreuther, K ;

Masters, CL ;

Li, QX .

AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1173-1181

← 1 2 3 4 5 →